InspireMD Inc.

Last updated September 27, 2026

Organization details

Legal name
InspireMD Inc.
Former names
Saguaro Resources, Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
3841 — Surgical & Medical Instruments & Apparatus
Jurisdiction of incorporation
Delaware
Headquarters city
Miami
Headquarters state / province
Florida
Headquarters country
Israel
Fiscal year end
December
Ticker symbol
NSPR
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001433607
EIN
26-2123838

Board of directors

Chief executives

Marvin Slosman · CEO and President
Dates unknown

Director election results

Annual meeting of June 3, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

4 of this board's directors also sit on 5 other boards. 5 are in the same sector.

Network of InspireMD Inc.'s board connections Beta Bionics Inc. Beta Bionics Inc. BioCardia Inc. BioCardia Inc. Kestra Medical Technologies Ltd. Kestra Medical Technol... Merit Medical Systems Inc. Merit Medical Systems... RxSight Inc. RxSight Inc. Danny L. Dearen Danny L. Dearen Marvin Slosman Marvin Slosman Raymond W. Cohen Raymond W. Cohen Scott R. Ward Scott R. Ward InspireMD Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$425,164
15 purchases by 4 insiders
Sold, last 12 months
$126,870
12 sales by 1 insider
Date Insider Transaction Shares Price Value
May 27, 2026 Paul Stuka Director Open-market purchase +20,000 $0.88 $17,600
May 19, 2026 Gleason Shane Thomas Officer (Chief Commercial Officer) Open-market sale −22,778 $1.01 $23,006
May 14, 2026 Paul Stuka Director Open-market purchase +5,000 $1.15 $5,750
May 13, 2026 Paul Stuka Director Open-market purchase +10,000 $1.16 $11,600
May 12, 2026 Marvin Slosman Director, Officer (CEO and President) Open-market purchase +21,000 $1.20 $25,200
May 11, 2026 Paul Stuka Director Open-market purchase +10,000 $1.19 $11,900
May 8, 2026 Paul Stuka Director Open-market purchase +65,626 $1.16 $76,126
May 7, 2026 Gary S. Roubin Director Open-market purchase +90,000 $1.18 $106,200
May 7, 2026 Scott R. Ward Director Open-market purchase +73,255 $1.15 $84,243
May 7, 2026 Paul Stuka Director Open-market purchase +6,378 $1.15 $7,335
May 6, 2026 Scott R. Ward Director Open-market purchase +15,995 $1.15 $18,394
May 6, 2026 Paul Stuka Director Open-market purchase +1,517 $1.12 $1,699
Feb 2, 2026 Gleason Shane Thomas Officer (Chief Commercial Officer) Open-market sale −2,000 $1.60 $3,200
Feb 2, 2026 Gleason Shane Thomas Officer (Chief Commercial Officer) Open-market sale −2,941 $1.59 $4,676
Jan 30, 2026 Gleason Shane Thomas Officer (Chief Commercial Officer) Open-market sale −2,900 $1.63 $4,727

Organizations in the same sector, closest in location and size first.

Questions about InspireMD Inc.

Who is the CEO of InspireMD Inc.?

Marvin Slosman is InspireMD Inc.'s CEO and President.

How many directors are on InspireMD Inc.'s board?

InspireMD Inc.'s board has 9 directors: Danny L. Dearen, Gary S. Roubin, Kathryn Arnold, Marvin Slosman, Michael Berman, Paul Stuka, Raymond W. Cohen, Scott R. Ward and Thomas J. Kester.

Are InspireMD Inc. insiders buying or selling shares?

Over the last 12 months, InspireMD Inc. insiders bought $425,164 of shares in 15 purchases and sold $126,870 of shares in 12 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="inspiremd-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.